STAGE IV RENAL PELVIS CANCER AJCC V8
Clinical trials for STAGE IV RENAL PELVIS CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL PELVIS CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV RENAL PELVIS CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for Tough-to-Treat bladder cancer
Disease control OngoingThis study tests whether adding the chemotherapy drug eribulin to the immunotherapy atezolizumab works better than atezolizumab alone for people with advanced urothelial cancer (a type of bladder cancer) that has spread or come back. The study includes 72 adults who cannot take t…
Matched conditions: STAGE IV RENAL PELVIS CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Could a common heart drug boost cancer immunotherapy?
Disease control OngoingThis study tests adding propranolol, a blood pressure drug, to standard immunotherapy for people with advanced bladder cancer that has spread. The goal is to see if the combination is safe and may help control the disease. Only 6 participants were enrolled, so results are very ea…
Matched conditions: STAGE IV RENAL PELVIS CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 01, 2026 15:57 UTC